PL438501A1 - Kompozycja w postaci nanoemulsji na bazie oleju roślinnego, kompozycja wielofazowa oraz sposób wytwarzania tych kompozycji - Google Patents

Kompozycja w postaci nanoemulsji na bazie oleju roślinnego, kompozycja wielofazowa oraz sposób wytwarzania tych kompozycji Download PDF

Info

Publication number
PL438501A1
PL438501A1 PL438501A PL43850121A PL438501A1 PL 438501 A1 PL438501 A1 PL 438501A1 PL 438501 A PL438501 A PL 438501A PL 43850121 A PL43850121 A PL 43850121A PL 438501 A1 PL438501 A1 PL 438501A1
Authority
PL
Poland
Prior art keywords
mass
parts
composition
vegetable oil
phase
Prior art date
Application number
PL438501A
Other languages
English (en)
Other versions
PL246054B1 (pl
Inventor
Katarzyna Małolepsza-Jarmołowska
Michał Smoleński
Original Assignee
Univ Medyczny Im Piastow Slaskich We Wroclawiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Medyczny Im Piastow Slaskich We Wroclawiu filed Critical Univ Medyczny Im Piastow Slaskich We Wroclawiu
Priority to PL438501A priority Critical patent/PL246054B1/pl
Priority to PCT/PL2022/000039 priority patent/WO2023287309A1/en
Priority to EP22783381.1A priority patent/EP4370096A1/en
Publication of PL438501A1 publication Critical patent/PL438501A1/pl
Publication of PL246054B1 publication Critical patent/PL246054B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Edible Oils And Fats (AREA)

Abstract

Pierwszym przedmiotem wynalazku jest kompozycja w postaci nanoemulsji na bazie oleju roślinnego, charakteryzująca się tym, że zawiera olej roślinny, który stanowi olej rzepakowy, w ilości od 10 do 60 części masowych oleju rzepakowego, od 12 do 20 części masowych poloksameru 188, od 40 do 60 części masowych wody oczyszczonej, od 1 do 12 części masowych Spanu 80, od 5 do 20 części masowych poliolu, od 0,10 do 0,50 części masowych kwasu mlekowego, od 0,5 do 5,0 części masowych klotrimazolu, przy czym krople fazy olejowej mają średnicę hydrodynamiczną od 50 nm do 70 nm. Drugim przedmiotem wynalazku jest kompozycja wielofazowa na bazie nanoemulsji oleju roślinnego, charakteryzująca się tym, że zawiera fazę polisacharydową w ilości od 10 do 50 części masowych i nanoemulsję wg pierwszego przedmiotu wynalazku w ilości od 50 do 90 części masowych, przy czym kompozycja wielofazowa ma postać nanoemulżelu, przy czym kompozycja wielofazowa ma lepkość dynamiczną od 220 mPa•s do 580 mPa•s. Wynalazek obejmuje także sposoby otrzymywania rzeczonych kompozycji.

Description

PL 438501 A1 2/25PL 438501 A1 3/25PL 438501 A1 4/25PL 438501 A1 /25PL 438501 A1 6/25PL 438501 A1 7/25PL 438501 A1 8/25PL 438501 A1 9/25PL 438501 A1 /25PL 438501 A1 11/25PL 438501 A1 12/25PL 438501 A1 13/25PL 438501 A1 14/25PL 438501 A1 /25PL 438501 A1 16/25PL 438501 A1 17/25PL 438501 A1 18/25PL 438501 A1 19/25PL 438501 A1 /25PL 438501 A1 21/25PL 438501 A1 22/25PL 438501 A1 23/25PL 438501 A1 24/25PL 438501 A1 /25 PL

Claims (1)

1.
PL438501A 2021-07-16 2021-07-16 Kompozycja farmaceutyczna w postaci nanoemulsji na bazie oleju roślinnego, kompozycja farmaceutyczna wielofazowa oraz sposób wytwarzania tych kompozycji farmaceutycznych PL246054B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL438501A PL246054B1 (pl) 2021-07-16 2021-07-16 Kompozycja farmaceutyczna w postaci nanoemulsji na bazie oleju roślinnego, kompozycja farmaceutyczna wielofazowa oraz sposób wytwarzania tych kompozycji farmaceutycznych
PCT/PL2022/000039 WO2023287309A1 (en) 2021-07-16 2022-07-15 Pharmaceutical composition in the form of vegetable oil-based nanoemulsion, multiphase composition and method of preparation of these compositions
EP22783381.1A EP4370096A1 (en) 2021-07-16 2022-07-15 Pharmaceutical composition in the form of vegetable oil-based nanoemulsion, multiphase composition and method of preparation of these compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL438501A PL246054B1 (pl) 2021-07-16 2021-07-16 Kompozycja farmaceutyczna w postaci nanoemulsji na bazie oleju roślinnego, kompozycja farmaceutyczna wielofazowa oraz sposób wytwarzania tych kompozycji farmaceutycznych

Publications (2)

Publication Number Publication Date
PL438501A1 true PL438501A1 (pl) 2023-01-23
PL246054B1 PL246054B1 (pl) 2024-11-25

Family

ID=83546936

Family Applications (1)

Application Number Title Priority Date Filing Date
PL438501A PL246054B1 (pl) 2021-07-16 2021-07-16 Kompozycja farmaceutyczna w postaci nanoemulsji na bazie oleju roślinnego, kompozycja farmaceutyczna wielofazowa oraz sposób wytwarzania tych kompozycji farmaceutycznych

Country Status (3)

Country Link
EP (1) EP4370096A1 (pl)
PL (1) PL246054B1 (pl)
WO (1) WO2023287309A1 (pl)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
KR20040028336A (ko) * 2002-09-30 2004-04-03 김종국 신규한 질내 투여용 항균 온도감응성 겔 조성물
CN1931163A (zh) * 2006-09-20 2007-03-21 西北农林科技大学 一种克霉唑纳米乳液药物及其制备方法
PL210178B1 (pl) * 2007-06-15 2011-12-30 Politechnika Wroclawska Sposób wytwarzania mikroemulsji stabilizowanej surfaktantami
EP2222340B1 (en) * 2007-11-28 2014-01-08 Commonwealth Scientific and Industrial Research Organisation Nanoemulsions
DE102008034944B4 (de) * 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion
DE202014010412U1 (de) * 2014-02-21 2015-09-01 Ursapharm Arzneimittel Gmbh Mikro- oder Nanoemulsion zur ophthalmologischen Anwendung
CN110664733A (zh) * 2019-10-09 2020-01-10 华欧研创生物科技(深圳)有限公司 用于女性阴道护理的玻尿酸纳米乳凝胶剂

Also Published As

Publication number Publication date
EP4370096A1 (en) 2024-05-22
WO2023287309A1 (en) 2023-01-19
PL246054B1 (pl) 2024-11-25

Similar Documents

Publication Publication Date Title
WO2010077707A3 (en) Method for preparing personal care composition comprising surfactant and high melting point fatty compound
MY160023A (en) Process for making high viscosity index lubricating base oils
SG179416A1 (en) Lubricant base oil, method for production thereof, and lubricant oil composition
BRPI0515091A (pt) composição de catalisador adequada para a hidroconversão de óleos pesados
BR112012005155A2 (pt) composição lubrificante,e, usos de uma composição lubrificante e de um líquido iônico
MX2018003286A (es) Metodo para preparar microcapsulas mediante emulsion doble.
SG10201808084XA (en) Method for preventing or reducing low speed pre-ignition
EP2271314A4 (en) COMPOSITIONS AND METHOD FOR THE PRODUCTION OF NANOEMULSIONS
MX2010003302A (es) Composiciones de fluido hidraulico para tractores y preparacion del mismo.
MX2021013678A (es) Mezcla de hidrocarburos que contiene componentes fosiles y renovables y procedimiento de produccion de dicha mezcla.
MY143562A (en) Enhanced oil delivery from structured surfactant formulations
BR112012006950A2 (pt) modificador de viscosidade para óleos lubrificantes, composição aditiva para óleos lubrificantes, e composição de óleo lubrificante
WO2009000068A8 (en) Drilling fluid additive and method for improving lubricity or increasing rate of penetration in a drilling operation
RU2016113169A (ru) Способ превращения жидкостей и восков процесса фишера-тропша в базовый компонент смазочного масла и/или моторное топливо
IL206412A0 (en) Universal synthetic lubricant, method and product-by-process to replace the lost sulfur lubrication when using low-sulfur diesel fuels
MX2016013467A (es) Composiciones colectoras y metodos para usar las mismas.
AR104258A1 (es) Composiciones de aditivos para fluidos de perforación y métodos para su uso
RU2017143896A (ru) Простые эфиры и родственные композиции и способы
MY204543A (en) Synthetic fluids with improved biodegradability
BR112017004618A2 (pt) modificador da capacidade de ruptura para poliésteres biodegradáveis
RU2017114926A (ru) Композиция смазочного масла
WO2013040331A3 (en) Method for preparing personal care composition comprising surfactant system and high melting point fatty compound
WO2019123261A3 (en) Oral compositions and methods of use
CN106084128A (zh) 润滑油抗凝剂及其制备方法与应用
WO2020131515A3 (en) Lubricant compositions with improved wear control